Loading rounds…
Loading rounds…
Explore funding rounds, the companies behind them and the investors taking part.
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| AI Develops AI-native finance platform for enterprises | €4M | Seed | Fintech | Germany | Investors | |
| LA Develops neuroplastic AI software for industrial control systems | £8.1M | Series A | Robotics |
Ranked by rounds participated in · All time
Metriport, Arintra, Multiplier
Transfyr, General Intuition, Castelion
Rillet, Castelion, Hadrian
SiFly Aviation, Apollo Atomics, Hopscotch Primary Care
Higgsfield, Lovable, Cambridge Aerospace
Explore published rounds while the next edition is being prepared.
| United Kingdom |
| Investors |
| B BIZAYCompany profile Provides digital platform for customized marketing materials, packaging, and promotional products Provides digital platform for customized marketing materials, packaging, and promotional products | $55M | Series DSeries C+ | Ecommerce | Portugal | Investors |
| TA Develops autonomous AI technology for financial crime investigations | $20M | Seed | Fintech | Israel | Investors |
| HT Healome TherapeuticsCompany profile Develops proprietary eye-drop matrix technology for ocular surface diseases Develops proprietary eye-drop matrix technology for ocular surface diseases | £2M | Seed | Biotech | United Kingdom | Investors |
| AD Arkenstone DefenseCompany profile Provides compliance infrastructure for commercial companies to enter federal market Provides compliance infrastructure for commercial companies to enter federal market | $35M | Seed | Defense tech | United States | Investors |
| EM Provides institutional digital asset infrastructure and trading venue | $76M | Series CSeries C+ | Fintech | United States | Investors |
| CT Cyllene TherapeuticsCompany profile Develops DNA medicines for severe neurogenic bladder conditions and other neurological diseases Develops DNA medicines for severe neurogenic bladder conditions and other neurological diseases | €33M | Series CSeries C+ | Biotech | France | Investors |
| P Develops advanced materials for industrial separation and water treatment | €2.4M | Pre-SeedPre-seed | Climate tech | Germany | Investors |
| C CurifyLabsCompany profile Transforms how personalized medicines are made with proprietary software and GMP-manufactured excipients Transforms how personalized medicines are made with proprietary software and GMP-manufactured excipients | $14M | Series A | Healthtech | Finland | Investors |